SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-102770
Filing Date
2023-04-17
Accepted
2023-04-17 06:13:55
Documents
16
Period of Report
2023-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462383d8k.htm   iXBRL 8-K 44974
2 EX-2.1 d462383dex21.htm EX-2.1 432596
3 EX-99.1 d462383dex991.htm EX-99.1 25020
7 GRAPHIC g462383g0417071856941.jpg GRAPHIC 3507
8 GRAPHIC g462383g0417071857066.jpg GRAPHIC 3794
  Complete submission text file 0001193125-23-102770.txt   751585

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20230415.xsd EX-101.SCH 2881
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20230415_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20230415_pre.xml EX-101.PRE 10833
10 EXTRACTED XBRL INSTANCE DOCUMENT d462383d8k_htm.xml XML 3237
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 23822745
SIC: 2834 Pharmaceutical Preparations